Metropolitan Life Insurance CO Magenta Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$6.03 - $15.24 $43,711 - $110,474	-7,249 Closed	0 $0
Q4 2019 Jul 12, 2023	BUY	$9.07 - $15.84 $65,748 - $114,824	7,249 New	7,249 $109,000
Q4 2019 Mar 30, 2023	SELL	$9.07 - $15.84 $1,532 - $2,676	-169 Reduced 2.28%	7,249 $109,000
Q4 2019 Feb 14, 2020	SELL	$9.07 - $15.84 $1,532 - $2,676	-169 Reduced 2.28%	7,249 $110,000
Q3 2019 Jul 12, 2023	BUY	$9.63 - $14.0 $71,435 - $103,852	7,418 New	7,418 $76,000
Q3 2019 Mar 30, 2023	BUY	$9.63 - $14.0 $71,435 - $103,852	7,418 New	7,418 $76,000
Q3 2019 Nov 14, 2019	BUY	$9.63 - $14.0 $71,435 - $103,852	7,418 New	7,418 $76,000
Q2 2019 Jul 12, 2023	BUY	$13.4 - $17.67 $21,681 - $28,590	1,618 New	1,618 $23.9 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.